Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alexion pharmaceuticals
7
×
biotech
7
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
clinical trials
deals
indiana blog main
indiana top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
fda
investing
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
boston
cancer immunotherapy
hepatitis b
medicare
novartis
What
drug
bio
roundup
medicines
pharma
alzheimer’s
companies
deal
dicerna
disease
gene
new
pharmaceutical
pharmaceuticals
plan
prices
research
typically
abandoning
advantages
ago
alternative
annual
assessed
attention
autoimmune
baggage
bails
bar
biotech
brand
bridgebio
brings
candidate
capital
car
caught
causing
communities
conference
Language
unset
Current search:
biotech
×
" alexion pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More